Clinical Trial Update: A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate the efficacy and safety of Cenerimod in active lupus nephritis on top of standard therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Cenerimod (cenerimod)

Snippet

Sponsor: Viatris Innovation GmbH | Conditions: Nephritis, Lupus, Lupus Erythematosus, Systemic | Phase 3 | Status: RECRUITING